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Stimulation of porcine platelets with ADP or thrombin and subsequent analyses of their cytoskeletons by 
SDS-polyacrylamide gel electrophoresis have shown the presence of a 30.5-kDa polypeptide in the 
cytoskeletons of activated as well as aggregated platelets. This poiypeptide comigrates with pure porcine 
platelet tropomyosin i  SDS geis, their mobilities being similarly and markedly decreased in the presence 
of 6 M urea. One-dimensional peptide mapping after limited proteolysis by Staphylococcus aweus 
protease gives the same pattern for pure tropomyosin and the 30.5-kDa polypeptide. This latter may thus 
be identified as the porcine platelet tropomyosin subunit, the role of which may not be solely structural. 
Porcine plate/et 
1. INTRODUCTION 
Upon exposure to various stimuli, circulating 
blood platelets are triggered into activity and 
undergo dramatic morphological and ultrastruc- 
tural changes that play an important role in 
hemostasis. Within seconds, their shape changes 
from smooth discoid to spheroid with several 
pseudopods and, if stimulation goes on, this ac- 
tivation normally leads to aggregation. Recently 
there has been increasing evidence for the involve- 
ment of contractile proteins in these platelet 
responses. Thus, one observes a significant in- 
crease in the polymerization of actin [ 1,2] which is 
already maximal with activation 121, and in the 
amounts of actin and myosin, associated with 
several other proteins, in the cytoskeletons of 
stimulated platelets [3]. 
In a comparative study of stimulations of por- 
cine platelets with ADP and thrombin, we have 
also consistentIy observed an increase in the 
amounts of a 30.5kDa polypeptide in the 
cytoskeletons of activated as well as aggregated 
Abbreviations: PRP, platelet-rich plasma; PGE,, pro- 
staglandin Et; PMSF, phenylmethylsulfonyl fluoride 
ADP stimulation Throm~in stimulation 
platelets. A 31-kDa polypeptide has also been 
observed in human platelets stimulated by throm- 
bin [4,5] and it has been suggested that it is 
equivalent in size to the monomer of platelet 
tropomyosin [5] without any other characteriza- 
tion. 
Tropomyosin has been purified from human [6], 
equine [7] and porcine [8] platelets, but its role is 
as yet unknown. An exclusively structural role has 
been assigned to non-muscle tropomyosins [9] and 
its involvement in such a rapid and highly plastic 
response as platelet activation may raise some 
questions. Therefore, the nature of the 30.5kDa 
polypeptide present in platelet cytoskeletons 
deserves further study. 
Our results allow the identification of this 
polypeptide as porcine platelet tropomyosin 
subunit. 
2. MATERIALS AND METHODS 
2.1. Materials 
PGEI, PMSF, human plasma thrombin 
(minimum 3000 NIH units/mg protein) were from 
Sigma, Dextran Tlo from Pharmacia and ultrapure 
urea from Serlabo. Pure porcine platelet 
164 
Published by Efsevier Science Publishers 3. V. 
00145793/84/$3.00 0 1984 Federation of European Biochemical Societies 
Volume 173, number 1 FEBS LETTERS July 1984 
tropomyosin was a gift from Dr E. der Terrossian 
(Biologie Physico-Chimique, Universite Paris Sud, 
Orsay). 
2.2. Platelet isolation 
Blood was collected directly from freshly killed 
pigs into citrate-phosphate-dextrose anticoagulant 
in plastic bottles and centrifuged at 280 x g and 
25°C for 10 min. The supernatant PRP was made 
7 ng/ml in PGEi and recentrifuged at 1900 x g for 
20 min to remove contaminant erythrocytes. 
Platelets were then isolated on Dextran TAO gra- 
dients by a modification of the method of [lo]: the 
PRP was loaded on two layers of 25 and 10% Dex- 
tran in Hepes buffer (137 mM NaCl, 2.7 mM KCI, 
3.2 mM NaHzPOd, 3.7 mM Hepes, 5.5 mM 
glucose; pH 7.4) containing 0.2pg PGEi. After 
20 min centrifugation at 2357 x g, the platelets had 
banded at the interface of the two Dextran layers 
and were recovered and resuspended in Hepes buf- 
fer containing 4 mM MgCL, diluted with the same 
buffer to 2 x lo* platelets/ml and progressively 
warmed to 37°C for 30 min. 
2.3. Activation and aggregation 
The suspended platelets were tested for activa- 
tion and aggregation by ADP or thrombin. 
Measurements by the turbidimetric method [l l] 
were made at 37°C in a Gilford spectrophotometer 
equipped with a variable speed stirrer (Spectra Stir 
2445), an expanded scale recorder, a recorder off- 
set and a thermoregulated sample compartment. 
Plastic cuvettes were used. 
Activation was usually obtained by addition of 
ADP at 40 PM or thrombin at 0.4-0.6 units/ml, in 
the presence of 4 mM EGTA. Aggregation was ob- 
tained with ADP and lo-20 mM Ca2+ or throm- 
bin and 2 mM Ca2+. 
2.4. Cytoskeleton isolation 
Cytoskeletons from identical amounts of 
platelets, activated or aggregated under the op- 
timal conditions thus defined, were obtained by 
lysis of these platelets with 1% Triton, 10 mM 
EGTA, 2 mM PMSF, 50 mM Tris (pH 7.4) and 
low-speed centrifugation of the lysate as in [3]. The 
pelleted cytoskeletons were washed twice by vortex 
mixing in the same lysis buffer (containing the 
same concentration of ADP, when stimulation was 
induced by this nucleotide). 
2.5. Analytical methods 
Washed cytoskeletons were dissolved in 4% 
SDS, 10% ,&mercaptoethanol, 10 mM EGTA and 
incubated in a boiling water bath for 30 min. The 
samples were then readjusted to the same volume, 
and electrophoresed through slab gels according to 
[ 121, using a uniform or 5-25% concave gradient 
of acrylamide concentrations for the resolving 
gels. 
Electrophoresis in urea was performed as in [13] 
with samples prepared in 3 M urea, stacking gels in 
3 M and resolving gels in 6 M urea. 
One-dimensional peptide maps of polypeptide 
bands isolated from the gels were obtained as in 
1141. 
3. RESULTS AND DISCUSSION 
SDS-polyacrylamide gel electrophoresis of the 
cytoskeletons of activated and aggregated porcine 
platelets revealed the appearance of new polypep- 
tide bands or the increase in intensity of bands 
preexisting in the cytoskeleton of resting platelets. 
Particularly, whether stimulation was obtained 
with ADP or with thrombin, the increase in a 
polypeptide of higher mobility than actin was con- 
sistently observed (fig. 1, 3A) and its apparent 
molecular mass was found to be 30.5 kDa (fig.2). 
This polypeptide comigrates with pure porcine 
tropomyosin subunit. The mobilities of both 
polypeptides were markedly reduced in the 
presence of 6 M urea and became indistinguishable 
from the actin bands of the cytoskeletons 
(fig.3A,B). 
The 30.5-kDa polypeptide and pure porcine 
tropomyosin bands were also isolated from SDS- 
polyacrylamide slab gels, submitted to limited pro- 
teolysis by Staphylococcus aureus V8 protease and 
reelectrophoresed. The proteolytic patterns given 
by these bands were similar, with a few polypep- 
tides of low M,, approximately between 20.1 and 
14.4 kDa (fig.4). 
The reported features strongly favor the iden- 
tification of the 30.5-kDa polypeptide found in the 
cytoskeletons of activated or aggregated porcine 
platelets as a tropomyosin subunit. 
Its molecular mass is similar to that reported for 
non-muscle tropomyosins, particularly platelet 
tropomyosins [6-81. It comigrates with pure por- 
cine tropomyosin in SDS-polyacrylamide gels and 
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Volume 173, number 1 FEBSLETTERS July 1984 
---t 
a. b c 4 9 a 
Fig. 1. SDS-polyacrylamide gel electrophoresis of Triton- 
insoluble cytoskeletons from resting and stimulated 
platelets. Lanes: (a) A4, standards - 1, myosin heavy 
chain (200000), 2, phosphorylase b (94000), 3, bovine 
serum albumin (67000), 4, ovalbumin (43000), 5, 
carbonic anhydrase (30000), 6, trypsin inhibitor 
(20 lOO), 7, cu-lactalbumin (14400) (from Pharmacia 
electrophoresis calibration kit, except for myosin heavy 
chain); (b) resting platelets; (c) ADP-activated platelets; 
(d) ADP-aggregated platelets; (e) pure porcine 
tropomyosin; (f) thrombin-activated platelets; (g) 
thrombin-aggregated platelets. A S-25% concave 
gradient of acrylamide was used for the resolving gel. 
undergoes an identical sharp decrease in mobility 
in the presence of high urea concentrations, a pro- 
perty associated almost exclusively with the 
tropomyosin molecule [ 131. Furthermore, limited 
proteolysis of both 30.5kDa polypeptide and 
tropomyosin subunit gave similar electrophoretic 
patterns. There are very few differences between 
those obtained with 1 and 50 ng protease for both 
polypeptides and this is also in keeping with the 
known periodic and conservative structure of 
tropomyosins. 
From immunofluorescence studies, tropomyosin 
has long been shown to associate with actin cables 
in stress fibers of non-muscle cells and an ex- 
clusively structural role has been envisaged for this 
protein in this class of cell [9]. Besides, the Ca2+ 
regulation of actomyosin-ATPase and contractili- 
ty, assumed by tropomyosin and its complexes 
with the troponin molecules in skeletal muscle, is 
effected mainly by phosphorylation of the myosin 
light chain in platelets [ 151. However, the ap- 
2.10L 
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Fig.2. 1%4, determination from S-25% gradient gels. 
(l-7) M, standards as indicated in fig.1. (v) 30.5 kDa 
and pure porcine tropomyosin. 
pearance of tropomyosin in cytoskeletons obtained 
from such a rapid phenomenon as platelet activa- 
tion, which is induced in a few seconds, may reveal 
some involvement of this protein in the dynamic 
functioning of platelet contractile proteins. Recent 
papers have shown the existence of tropomyosin 
bound to the erythrocyte membrane [16,17] and 
even in the ruffling lamellae of normal and 
transformed cells [18], and some role in the regula- 
tion of actin interactions has been suggested by the 
authors. Moreover, an immunofluorescence study 
on platelets’ spreading on a surface, a process 
which causes shape changes similar to those occur- 
ring in platelet activation, has shown a strong 
decoration of the pseudopods in the dendritic and 
late intermediate stages by antibodies to 
tropomyosin [19]. The role of tropomyosin may 
thus be more complex than expected. Work is cur- 
rently underway to study further the interactions 
of tropomyosin with other proteins detected in the 
cytoskeletons of stimulated platelets. 
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Fig.3. SDS-polyacrylamide gel electrophoresis on 10% acrylamide of cytoskeletons from stimulated platelets. (A) 
Without urea; (B) in the presence of 6 M urea. Lanes: (a) M, standards numbered as in fig.1; (b) ADP-activated 
platelets; (c) ADP-aggregated platelets; (d) ADP-activated platelets + pure porcine tropomyosin; (e) tropomyosin (lower 
band in A); (f) thrombin-activated platelets; (g) thrombin-aggregated platelets; (h) thrombin-activated platelets + pure 
tropomyosin; (ij) 30.5kDa bands isolated from thrombin and ADP-aggregated platelets, respectively, and 
reelectrophoresed. 
cd a fg h 
Fig.4. Comparison of partial proteolyses during 
reelectrophoresis of 30.5kDa and tropomyosin 
polypeptides. A 15% acrylamide resolving gel was used. 
Lanes: (a) 42-kDa polypeptide (actin) (as a control of 
protease activity); (b) III, standards as in fig.1; (c,e,g) 
porcine tropomyosin; (d,f,h) 30.5kDa polypeptide. 
Amounts of protease used: 1 ng (c,d), 5 ng (e,f), 50 ng 
(a,g,h). 
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